following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.
.
.
.
. and prevention says hepatitis a is a vaccine-preventable, communicable disease of the liver caused by a virus. it is usually transmitted person-to-person or by consuming